About this trial
Colorectal cancer frequently presents with liver metastases, and complete removal of both primary and liver tumors can significantly improve survival. Simultaneous resection (SA) of the colon and liver is increasingly used and is considered safe when minor liver resections are performed, offering advantages such as shorter hospitalization, fewer complications, and faster chemotherapy initiation.
However, the best sequence of resection, liver-first or colon-first, remains uncertain, as each has potential benefits and drawbacks, particularly regarding anastomotic healing. Minimally invasive approaches to SA show similar outcomes to open surgery, though limited data suggest that resection order may affect blood loss.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients diagnosed with colorectal cancer with synchronous liver metastases during the reference period, who underwent simultaneous resection.
Disqualifiers
Simultaneous emergency resection due to symptoms of the primary tumor.
Presence of extrahepatic metastatic disease confirmed at the time of resection or diagnosis.
High surgical risk defined as an ASA risk score greater than 3.
At least 10 cases performed by the invited center during the study period.
Trial population
Patients undergoing simultaneous treatment of colorectal cancer and liver metastases using open, laparoscopic, and robotic surgery between 2015 and 2023 in participating centers
Trial design
Cohort
Retrospective
Treatments tested in this trial
Data collection
Procedure/SurgeryData collection to assess whether the order of resection of the site in a simultaneous approach (liver first vs. colon first) in colorectal cancer with liver metastases affects overall postoperative morbidity.
Treatment groups
Trial outcomes
Primary outcomes
Difference in overall morbidity rates
Measurement of the difference in overall morbidity rates between both approaches (liver first vs. colon first) in colorectal cancer with liver metastasis influences postoperative
Secondary outcomes
Mortality
Evaluation of the postoperative mortality for both approaches, (liver first vs. colon first), when performed via laparoscopic or robotic surgery
Overall survival
Compare the overall survival of patients with a diagnosis of colorectal cancer between both approaches (liver first vs. colon first), when performed via laparoscopic or robotic surgery
Disease-free survival
Compare the disease-free survival of patients with a diagnosis of colorectal cancer between both approaches (liver first vs. colon first), when performed via laparoscopic or robotic surgery
Recurrence sites
Compare the recurrence sites in patients with a diagnosis of colorectal cancer between both approaches (liver first vs. colon first), when performed via laparoscopic or robotic surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.